These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 38462041

  • 1. Novel pharmacological targets for GABAergic dysfunction in ADHD.
    Ferranti AS, Luessen DJ, Niswender CM.
    Neuropharmacology; 2024 May 15; 249():109897. PubMed ID: 38462041
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Parvalbumin interneuron deficiency in the prefrontal and motor cortices of spontaneously hypertensive rats: an attention-deficit hyperactivity disorder animal model insight.
    Bogdańska-Chomczyk E, Równiak M, Huang AC, Kozłowska A.
    Front Psychiatry; 2024 May 15; 15():1359237. PubMed ID: 38600979
    [Abstract] [Full Text] [Related]

  • 4. Reduced Glx and GABA Inductions in the Anterior Cingulate Cortex and Caudate Nucleus Are Related to Impaired Control of Attention in Attention-Deficit/Hyperactivity Disorder.
    Mamiya PC, Richards TL, Edden RAE, Lee AKC, Stein MA, Kuhl PK.
    Int J Mol Sci; 2022 Apr 23; 23(9):. PubMed ID: 35563067
    [Abstract] [Full Text] [Related]

  • 5. Aberrant regulation of synchronous network activity by the attention-deficit/hyperactivity disorder-associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex.
    Zhong P, Liu W, Yan Z.
    J Physiol; 2016 Jan 01; 594(1):135-47. PubMed ID: 26541360
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF.
    CNS Drugs; 2009 Jan 01; 23 Suppl 1():33-41. PubMed ID: 19621976
    [Abstract] [Full Text] [Related]

  • 8. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.
    Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD.
    Neuropsychol Rev; 2007 Mar 01; 17(1):39-59. PubMed ID: 17318414
    [Abstract] [Full Text] [Related]

  • 9. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation.
    Mortimer N, Ganster T, O'Leary A, Popp S, Freudenberg F, Reif A, Soler Artigas M, Ribasés M, Ramos-Quiroga JA, Lesch KP, Rivero O.
    Neuropharmacology; 2019 Sep 15; 156():107557. PubMed ID: 30849401
    [Abstract] [Full Text] [Related]

  • 10. Hyperactivity and impulsivity in adult attention-deficit/hyperactivity disorder is related to glutamatergic dysfunction in the anterior cingulate cortex.
    Bauer J, Werner A, Kohl W, Kugel H, Shushakova A, Pedersen A, Ohrmann P.
    World J Biol Psychiatry; 2018 Oct 15; 19(7):538-546. PubMed ID: 27973969
    [Abstract] [Full Text] [Related]

  • 11. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients.
    Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ.
    Neuroimage Clin; 2017 Oct 15; 15():812-818. PubMed ID: 28725548
    [Abstract] [Full Text] [Related]

  • 12. Impulsivity and Aggression in Female BPD and ADHD Patients: Association with ACC Glutamate and GABA Concentrations.
    Ende G, Cackowski S, Van Eijk J, Sack M, Demirakca T, Kleindienst N, Bohus M, Sobanski E, Krause-Utz A, Schmahl C.
    Neuropsychopharmacology; 2016 Jan 15; 41(2):410-8. PubMed ID: 26040503
    [Abstract] [Full Text] [Related]

  • 13. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
    Brikell I, Wimberley T, Albiñana C, Pedersen EM, Vilhjálmsson BJ, Agerbo E, Demontis D, Børglum AD, Schork AJ, LaBianca S, Werge T, Mors O, Hougaard DM, Thapar A, Mortensen PB, Dalsgaard S.
    Am J Psychiatry; 2021 Sep 01; 178(9):854-864. PubMed ID: 34154395
    [Abstract] [Full Text] [Related]

  • 14. Association of dopaminergic/GABAergic genes with attention deficit hyperactivity disorder in children.
    Wang GX, Ma YH, Wang SF, Ren GF, Guo H.
    Mol Med Rep; 2012 Nov 01; 6(5):1093-8. PubMed ID: 22895683
    [Abstract] [Full Text] [Related]

  • 15. Mice with reduced glutamate transporter GLT1 expression exhibit behaviors related to attention-deficit/hyperactivity disorder.
    Hiraoka Y, Sugiyama K, Nagaoka D, Tsutsui-Kimura I, Tanaka KF, Tanaka K.
    Biochem Biophys Res Commun; 2021 Aug 27; 567():161-165. PubMed ID: 34166912
    [Abstract] [Full Text] [Related]

  • 16. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.
    Sergeant J.
    Neurosci Biobehav Rev; 2000 Jan 27; 24(1):7-12. PubMed ID: 10654654
    [Abstract] [Full Text] [Related]

  • 17. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB.
    J Clin Child Psychol; 2001 Mar 27; 30(1):98-109. PubMed ID: 11294083
    [Abstract] [Full Text] [Related]

  • 18. Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior.
    Li Y, Yin A, Sun X, Zhang M, Zhang J, Wang P, Xie R, Li W, Fan Z, Zhu Y, Wang H, Dong H, Wu S, Xiong L.
    J Clin Invest; 2017 Dec 01; 127(12):4270-4284. PubMed ID: 29058689
    [Abstract] [Full Text] [Related]

  • 19. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
    Genro JP, Kieling C, Rohde LA, Hutz MH.
    Expert Rev Neurother; 2010 Apr 01; 10(4):587-601. PubMed ID: 20367210
    [Abstract] [Full Text] [Related]

  • 20. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D, Lepagnol-Bestel AM, Grosbellet E, Gorwood P, Simonneau M.
    Med Sci (Paris); 2010 May 01; 26(5):487-96. PubMed ID: 20510147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.